Literature DB >> 414866

An immunoglobulin heavy chain variable region (VH) marker associated with cross-reactive idiotypes in man.

T Feizi, J Lecomte, R Childs.   

Abstract

The VH specificities of two rabbit antisera raised against the H chains of two human IgM cold agglutinins were studied with the aid of proteins on which the VH sequence data are available. They were found to recognize a new VH antigen (VHMar), which may represent a subgroup of VHI. This antigen is found on anti-Ii antibodies which have cross-reactive idiotypes. It is moderately well-expressed in normal gamma globulin and strongly expressed on 8% of unselected myeloma and macroglobulinaemia proteins. There is evidence to suggest that a proportion of the cross-reactive idiotypes among the anti-Ii antibodies involve this VH antigen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 414866      PMCID: PMC1541133     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function.

Authors:  J Oudin; P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

2.  Cross idiotypic specificity among cold agglutinins in relation to combining activity for blood group-related antigens.

Authors:  T Feizi; H G Kunkel; D Roelcke
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

3.  Bence Jones proteins and light chains of immunoglobulins. IV. Immunochemical differentiation among proteins within each of the three established kappa-chain classes.

Authors:  A Solomon; C L McLaughlin
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

4.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

5.  [The primary structure of a monoclonal IgA-immunoglobulin (IgA Tro.), II. The amino acid sequence of the H-chain, alpha-type, subgroup III; structure of the complete IgA-molecule (author's transl)].

Authors:  H Kratzin; P Altevogt; E Ruban; A Kortt; K Staroscik; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-08

6.  Partial amino acid sequence of an IgA2 human immunoglobulin heavy chain.

Authors:  C Wolfenstein-Todel; B Frangione; E C Franklin
Journal:  Biochim Biophys Acta       Date:  1975-02-27

7.  Cross idiotypic specificity among heavy chains of macroglobulins with blood group I and i specificities.

Authors:  R Childs; T Feizi
Journal:  Nature       Date:  1975-06-12       Impact factor: 49.962

8.  The switch point in mu heavy chains of human IgM immunoglobulins.

Authors:  G Florent; D Lehman; F W Putnam
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

9.  [The primary structure of a monoclonal IgM-immunoglobulin (macroglobulin Gal.), I. The amino acid sequence of the L-chain of kappa-type, subgroup I (author's transl)].

Authors:  C J Laure; S Watanabe; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973 Oct-Nov

10.  Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities.

Authors:  H G Kunkel; R J Winchester; F G Joslin; J D Capra
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  3 in total

1.  Investigation of the idiotypic determinants of IgM monoclonal proteins associated with neuropathy.

Authors:  S W Evans; N A Gregson; S L Leibowitz; N R Ling
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  Immunoglobulin VH determinants defined by monoclonal antibodies.

Authors:  H Kubagawa; M Mayumi; J F Kearney; M D Cooper
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

3.  Anti-idiotypic antibodies to the Coombs antibody in NZB F1 mice.

Authors:  P L Cohen; R A Eisenberg
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.